SWK Holdings Corp (SWKHL) is the 271st largest of 300 Specialty Finance companies by market capitalisation, at 310.13 Mn, behind Horizon Technology Finance Corp at 312.20 Mn. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IX | Orix Corp | primary | F-06 | Lending and Credit | FG-02 | 43.75 Bn | 10.91 | 1.95 | 43.75 Bn |
| 2 | RPRX | Royalty Pharma plc | primary | F-06 | Lending and Credit | FG-02 | 26.67 Bn | 19.76 | 10.52 | 25.83 Bn |
| 3 | RGLD | Royal Gold Inc | primary | F-06 | Lending and Credit | FG-02 | 21.79 Bn | 29.25 | 14.08 | 21.60 Bn |
| 4 | OR | OR Royalties Inc. | primary | F-06 | Lending and Credit | FG-02 | 6.82 Bn | 18.04 | 18.79 | 6.74 Bn |
| 5 | ECPG | Encore Capital Group Inc | primary | F-06 | Lending and Credit | FG-02 | 2.10 Bn | 6.96 | 1.10 | 1.92 Bn |
| 6 | ATLC | Atlanticus Holdings Corp | primary | F-06 | Lending and Credit | FG-02 | 1.40 Bn | 9.69 | 0.53 | 0.85 Bn |
| 7 | JCAP | Jefferson Capital, Inc. / DE | primary | F-06 | Lending and Credit | FG-02 | 1.19 Bn | 8.14 | 1.87 | 1.17 Bn |
| 8 | UPBD | Upbound Group, Inc. | primary | F-06 | Lending and Credit | FG-02 | 1.06 Bn | 11.79 | 0.22 | 0.96 Bn |
| 9 | LU | Lufax Holding Ltd | primary | F-06 | Lending and Credit | FG-02 | 1.06 Bn | -2.08 | 0.30 | -1.57 Bn |
| 10 | BUR | Burford Capital Ltd | primary | F-06 | Lending and Credit | FG-02 | 0.96 Bn | -0.57 | 0.50 | 0.96 Bn |
| 11 | MTA | Metalla Royalty & Streaming Ltd. | primary | F-06 | Lending and Credit | FG-02 | 0.93 Bn | -541.24 | — | 0.92 Bn |
| 12 | PRAA | Pra Group Inc | primary | F-06 | Lending and Credit | FG-02 | 0.72 Bn | -2.82 | 0.54 | 0.58 Bn |
| 13 | UROY | Uranium Royalty Corp. | primary | F-06 | Lending and Credit | FG-02 | 0.59 Bn | 218.01 | 15.07 | 0.49 Bn |
| 14 | GROY | Gold Royalty Corp. | primary | F-06 | Lending and Credit | FG-02 | 0.57 Bn | 178.46 | 25.22 | 0.55 Bn |
| 15 | OPFI | OppFi Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.51 Bn | 2.77 | 1.40 | 0.42 Bn |
| 16 | ORBS | Eightco Holdings Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.40 Bn | -1.52 | 15.86 | 0.34 Bn |
| 17 | ALUB-UN | Alussa Energy Acquisition Corp. II | primary | F-06 | Lending and Credit | FG-02 | 0.37 Bn | 103.13 | — | 0.37 Bn |
| 18 | SWKHL | SWK Holdings Corp | primary | F-06 | Lending and Credit | FG-02 | 0.31 Bn | -332.76 | 7.48 | 0.27 Bn |
| 19 | TROO | Troops, Inc. /Cayman Islands/ | primary | F-06 | Lending and Credit | FG-02 | 0.26 Bn | -9.35 | 16.01 | 0.25 Bn |
| 20 | SUIG | SUI Group Holdings Ltd. | primary | F-06 | Lending and Credit | FG-02 | 0.08 Bn | -0.27 | 26.24 | 0.08 Bn |
| 21 | MGTE | Marblegate Capital Corp | primary | F-06 | Lending and Credit | FG-02 | 0.08 Bn | -1.70 | 1.27 | 0.07 Bn |
| 22 | ICRP | InPoint Commercial Real Estate Income, Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.06 Bn | -3.17 | 2.59 | 0.00 Bn |
| 23 | RMCO | Royalty Management Holding Corp | primary | F-06 | Lending and Credit | FG-02 | 0.04 Bn | -332.32 | 6.97 | 0.04 Bn |
| 24 | BMNM | Bimini Capital Management, Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.03 Bn | 5.44 | 1.32 | 0.04 Bn |
| 25 | ZLME | Zhanling International Ltd | primary | F-06 | Lending and Credit | FG-02 | 0.03 Bn | -721.26 | — | 0.03 Bn |
| 26 | ABCP | AmBase Corp | primary | F-06 | Lending and Credit | FG-02 | 0.02 Bn | -9.06 | — | 0.03 Bn |
| 27 | STQN | Strategic Acquisitions Inc /Nv/ | primary | F-06 | Lending and Credit | FG-02 | 0.02 Bn | -131.82 | — | 0.02 Bn |
| 28 | KARX | Karbon-X Corp. | primary | F-06 | Lending and Credit | FG-02 | 0.01 Bn | -1.01 | 0.20 | 0.01 Bn |
| 29 | SPST | Superstar Platforms Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.01 Bn | -22.51 | — | 0.01 Bn |
| 30 | AIHS | Senmiao Technology Ltd | primary | F-06 | Lending and Credit | FG-02 | 0.01 Bn | -0.27 | 5.15 | 0.00 Bn |
| 31 | SPFX | Standard Premium Finance Holdings, Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.01 Bn | 7.06 | 0.69 | 0.01 Bn |
| 32 | SUND | Sundance Strategies, Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.01 Bn | — | — | 0.01 Bn |
| 33 | TCRI | TechCom, Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.01 Bn | -111.02 | — | 0.01 Bn |
| 34 | SRCO | Sparta Commercial Services, Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.00 Bn | -1.26 | 12.42 | 0.01 Bn |
| 35 | BENF | Beneficient | primary | F-06 | Lending and Credit | FG-02 | 0.00 Bn | -0.04 | 0.05 | 0.00 Bn |
| 36 | ALDA | Atlantica Inc | primary | F-06 | Lending and Credit | FG-02 | 0.00 Bn | — | — | 0.00 Bn |
| 37 | DEVSF | DevvStream Corp. | primary | F-06 | Lending and Credit | FG-02 | 0.00 Bn | -0.21 | 71.40 | 0.00 Bn |
| 38 | SHFS | SHF Holdings, Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.00 Bn | -0.22 | 0.14 | 0.00 Bn |
| 39 | QPRC | Quest Patent Research Corp | primary | F-06 | Lending and Credit | FG-02 | 0.00 Bn | -0.09 | 0.28 | 0.00 Bn |
| 40 | FTFT | Future FinTech Group Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.00 Bn | -0.17 | 0.27 | 0.00 Bn |
| 41 | JNJ | Johnson & Johnson | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 641.22 Bn | 30.48 | 6.55 | 620.47 Bn |
| 42 | ABBV | AbbVie Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 446.28 Bn | 70.66 | 6.93 | 439.71 Bn |
| 43 | CAT | Caterpillar Inc | secondary | I-05 | Machinery | IG-02 | 371.25 Bn | 34.24 | 4.97 | 364.53 Bn |
| 44 | MRK | Merck & Co., Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 357.56 Bn | 112.83 | 5.37 | 350.42 Bn |
| 45 | MBFJF | Mitsubishi Ufj Financial Group Inc | secondary | F-02 | Banking | FG-01 | 296.69 Bn | 18.42 | 5.61 | -87.63 Bn |
| 46 | NVS | Novartis Ag | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 268.11 Bn | 9.31 | 3.90 | 260.42 Bn |
| 47 | TOYOF | Toyota Motor Corp/ | secondary | D-01 | Automobiles and Components | DG-01 | 251.54 Bn | 8.68 | 0.75 | 167.78 Bn |
| 48 | IBM | International Business Machines Corp | secondary | T-43 | Cloud Computing | TG-07 | 223.72 Bn | 20.86 | 3.24 | 212.37 Bn |
| 49 | DE | Deere & Co | secondary | I-06 | Machinery | IG-02 | 183.02 Bn | 40.22 | 3.81 | 174.10 Bn |
| 50 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 179.52 Bn | -62.01 | 5.89 | 176.34 Bn |
| 51 | BBVA | Banco Bilbao Vizcaya Argentaria, S.A. | secondary | F-02 | Banking | FG-01 | 166.87 Bn | 12.87 | — | 166.87 Bn |
| 52 | PFE | Pfizer Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 156.86 Bn | 35.91 | 2.46 | 145.17 Bn |
| 53 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 131.47 Bn | 29.84 | 10.44 | 123.62 Bn |
| 54 | HMC | Honda Motor Co Ltd | secondary | D-01 | Automobiles and Components | DG-01 | 126.37 Bn | 66.32 | 1.16 | 86.24 Bn |
| 55 | SMFG | Sumitomo Mitsui Financial Group, Inc. | secondary | F-02 | Banking | FG-01 | 102.34 Bn | 8.79 | -91.45 | 102.34 Bn |
| 56 | F-PB | Ford Motor Co | secondary | D-01 | Automobiles and Components | DG-01 | 79.06 Bn | -10.69 | 0.42 | 47.73 Bn |
| 57 | GM | General Motors Co | secondary | D-01 | Automobiles and Components | DG-01 | 76.21 Bn | 40.80 | 0.41 | 51.49 Bn |
| 58 | HPE | Hewlett Packard Enterprise Co | secondary | T-12 | Computer Hardware | TG-02 | 75.24 Bn | 28.13 | 1.80 | 69.02 Bn |
| 59 | PCAR | Paccar Inc | secondary | I-05 | Machinery | IG-02 | 64.67 Bn | 25.82 | 2.32 | 56.00 Bn |
| 60 | AJG | Arthur J. Gallagher & Co. | secondary | F-16 | Insurance | FG-04 | 62.87 Bn | 39.92 | 3.99 | 61.48 Bn |
| 61 | O | Realty Income Corp | secondary | R-06 | Property REITs | RG-01 | 55.67 Bn | 43.92 | 9.19 | 55.67 Bn |
| 62 | SNY | Sanofi | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 52.10 Bn | 11.18 | 0.97 | 44.72 Bn |
| 63 | PSA | Public Storage | secondary | R-08 | Property REITs | RG-01 | 51.85 Bn | 28.10 | 10.60 | 51.59 Bn |
| 64 | FITB | Fifth Third Bancorp | secondary | F-01 | Banking | FG-01 | 49.35 Bn | 18.55 | 4.86 | 25.63 Bn |
| 65 | MSTR | Strategy Inc | secondary | T-23 | Business Applications | TG-03 | 46.07 Bn | -1.47 | 92.44 | 43.62 Bn |
| 66 | RVMD | Revolution Medicines, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 43.01 Bn | -24.32 | — | 43.01 Bn |
| 67 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.25 Bn | 60.71 | 2.44 | 38.60 Bn |
| 68 | MTB | M&T Bank Corp | secondary | F-01 | Banking | FG-01 | 34.61 Bn | 12.05 | 3.47 | 34.61 Bn |
| 69 | HBAN | Huntington Bancshares Inc /Md/ | secondary | F-01 | Banking | FG-01 | 33.54 Bn | 14.93 | 3.45 | 29.01 Bn |
| 70 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 33.06 Bn | 51.41 | 3.07 | 31.60 Bn |
| 71 | BAP | Credicorp Ltd | secondary | F-02 | Banking | FG-01 | 30.07 Bn | 3.39 | — | 30.07 Bn |
| 72 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 29.30 Bn | 14.29 | 1.38 | 27.19 Bn |
| 73 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 29.30 Bn | -19.74 | 2,682.37 | 29.30 Bn |
| 74 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.68 Bn | -31.62 | 24.33 | 26.52 Bn |
| 75 | CINF | Cincinnati Financial Corp | secondary | F-13 | Insurance | FG-04 | 26.08 Bn | 8.04 | 1.87 | 24.19 Bn |
| 76 | RF | Regions Financial Corp | secondary | F-01 | Banking | FG-01 | 25.37 Bn | 11.80 | 3.33 | 25.37 Bn |
| 77 | SYF | Synchrony Financial | secondary | F-04 | Lending and Credit | FG-02 | 25.17 Bn | 7.33 | 1.29 | 8.98 Bn |
| 78 | INCY | Incyte Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 24.82 Bn | 15.39 | 4.26 | 20.28 Bn |
| 79 | FCNCA | First Citizens Bancshares Inc /De/ | secondary | F-01 | Banking | FG-01 | 24.69 Bn | 10.89 | 89.80 | 24.17 Bn |
| 80 | AER | AerCap Holdings N.V. | secondary | I-01 | Aerospace and Defense | IG-01 | 24.26 Bn | 5.74 | 2.71 | 24.26 Bn |
| 81 | KEY | Keycorp /New/ | secondary | F-01 | Banking | FG-01 | 23.20 Bn | 12.29 | 2.98 | -24.50 Bn |
| 82 | UTHR | UNITED THERAPEUTICS Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 21.39 Bn | 16.32 | 6.78 | 18.73 Bn |
| 83 | SNX | Td Synnex Corp | secondary | T-64 | Technology Services | TG-11 | 20.55 Bn | 18.09 | 0.29 | 19.46 Bn |
| 84 | SNA | Snap-on Inc | secondary | I-08 | Machinery | IG-02 | 19.37 Bn | 18.30 | 3.67 | 17.73 Bn |
| 85 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 18.85 Bn | -45.90 | 1.28 | 17.96 Bn |
| 86 | LEN | Lennar Corp /New/ | secondary | D-08 | Homebuilding | DG-03 | 18.65 Bn | 9.33 | 0.57 | 16.46 Bn |
| 87 | FTAI | FTAI Aviation Ltd. | secondary | I-01 | Aerospace and Defense | IG-01 | 18.50 Bn | 38.72 | 5.94 | 18.16 Bn |
| 88 | CNH | CNH Industrial N.V. | secondary | I-06 | Machinery | IG-02 | 16.88 Bn | 64.92 | 0.93 | 15.01 Bn |
| 89 | CBSH | Commerce Bancshares Inc /Mo/ | secondary | F-01 | Banking | FG-01 | 16.69 Bn | 28.25 | 8.95 | 16.48 Bn |
| 90 | ZTO | ZTO Express (Cayman) Inc. | secondary | I-23 | Transportation | IG-05 | 16.67 Bn | 11.21 | 2.13 | 12.07 Bn |
| 91 | NBIX | Neurocrine Biosciences Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.92 Bn | 22.57 | 4.72 | 15.53 Bn |
| 92 | KIM | Kimco Realty Corp | secondary | R-03 | Property REITs | RG-01 | 15.63 Bn | 27.18 | 7.25 | 15.63 Bn |
| 93 | JAZZ | Jazz Pharmaceuticals plc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.18 Bn | 16.14 | 3.30 | 13.56 Bn |
| 94 | PNFP | Pinnacle Financial Partners, Inc. | secondary | F-01 | Banking | FG-01 | 14.91 Bn | 20.18 | 13.38 | 7.26 Bn |
| 95 | EXEL | Exelixis, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.50 Bn | 16.85 | 5.95 | 13.66 Bn |
| 96 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.36 Bn | 40.31 | 4.09 | 13.75 Bn |
| 97 | AIZ | Assurant, Inc. | secondary | F-13 | Insurance | FG-04 | 13.90 Bn | 13.07 | 1.03 | 11.87 Bn |
| 98 | TXT | Textron Inc | secondary | I-01 | Aerospace and Defense | IG-01 | 13.72 Bn | 14.64 | 0.90 | 12.29 Bn |
| 99 | ALLY | Ally Financial Inc. | secondary | F-02 | Banking | FG-01 | 12.94 Bn | 9.74 | 1.49 | 5.10 Bn |
| 100 | CORT | Corcept Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 12.19 Bn | 224.86 | 14.67 | 11.88 Bn |
| 101 | JEF | Jefferies Financial Group Inc. | secondary | F-17 | Capital Markets | FG-05 | 11.50 Bn | 14.44 | 0.97 | -3.95 Bn |
| 102 | KYMR | Kymera Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.50 Bn | -38.37 | 109.49 | 10.81 Bn |
| 103 | AXSM | Axsome Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.84 Bn | -70.52 | 13.96 | 10.52 Bn |
| 104 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.34 Bn | -65.67 | 16.88 | 10.23 Bn |
| 105 | SSB | SouthState Bank Corp | secondary | F-01 | Banking | FG-01 | 10.22 Bn | 10.75 | 35.66 | 7.84 Bn |
| 106 | CFR | Cullen/Frost Bankers, Inc. | secondary | F-01 | Banking | FG-01 | 10.14 Bn | 14.98 | 77.95 | 3.64 Bn |
| 107 | WTFC | Wintrust Financial Corp | secondary | F-01 | Banking | FG-01 | 10.11 Bn | 11.92 | 3.53 | -62.06 Bn |
| 108 | FCFS | FirstCash Holdings, Inc. | secondary | F-04 | Lending and Credit | FG-02 | 9.99 Bn | 25.73 | 2.42 | 9.82 Bn |
| 109 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 9.89 Bn | -25.93 | — | 9.13 Bn |
| 110 | CYTK | Cytokinetics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.85 Bn | -13.43 | 145.61 | 8.69 Bn |
| 111 | NUVL | Nuvalent, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 112 | AVB | Avalonbay Communities Inc | secondary | R-01 | Property REITs | RG-01 | 9.67 Bn | 9.28 | 3.14 | 9.87 Bn |
| 113 | CRNX | Crinetics Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 213.22 | 8.99 Bn |
| 114 | AGCO | Agco Corp /De | secondary | I-06 | Machinery | IG-02 | 8.85 Bn | 18.36 | 0.86 | 8.28 Bn |
| 115 | GPCR | Structure Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.67 Bn | -46.08 | — | 8.67 Bn |
| 116 | LAD | Lithia Motors Inc | secondary | D-37 | Retail | DG-10 | 8.20 Bn | 11.39 | 0.22 | 7.84 Bn |
| 117 | ALKS | Alkermes plc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.63 Bn | 115.43 | 4.58 | 6.98 Bn |
| 118 | VLY | Valley National Bancorp | secondary | F-01 | Banking | FG-01 | 7.58 Bn | 11.42 | 105.42 | 7.25 Bn |
| 119 | IDA | Idacorp Inc | secondary | U-04 | Regulated Utilities | UG-02 | 7.58 Bn | 22.33 | 4.20 | 7.49 Bn |
| 120 | FAF | First American Financial Corp | secondary | F-14 | Insurance | FG-04 | 7.33 Bn | 9.80 | 0.92 | 4.21 Bn |
| 121 | TEX | Terex Corp | secondary | I-05 | Machinery | IG-02 | 6.88 Bn | 46.18 | 1.03 | 6.47 Bn |
| 122 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.35 Bn | -708.81 | 4,560.40 | 6.35 Bn |
| 123 | TVTX | Travere Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.33 Bn | -145.56 | 10.70 | 6.21 Bn |
| 124 | GATX | Gatx Corp | secondary | I-11 | Machinery | IG-02 | 6.30 Bn | 26.82 | 3.07 | 6.30 Bn |
| 125 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.29 Bn | -38.60 | 1.18 | 5.91 Bn |
| 126 | BLTE | Belite Bio, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.99 Bn | 0.08 | — | 5.99 Bn |
| 127 | LQDA | Liquidia Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.98 Bn | 43.18 | 13.27 | 5.70 Bn |
| 128 | HOMB | Home Bancshares Inc | secondary | F-01 | Banking | FG-01 | 5.95 Bn | 12.41 | 128.63 | 4.90 Bn |
| 129 | AMRN | Amarin Corp Plc\Uk | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.89 Bn | -217.10 | 31.62 | 5.57 Bn |
| 130 | STWD | Starwood Property Trust, Inc. | secondary | F-08 | Lending and Credit | FG-02 | 5.71 Bn | 21.58 | 2.84 | 3.54 Bn |
| 131 | RUSHA | Rush Enterprises Inc \Tx\ | secondary | I-31 | Distribution and Rental | IG-07 | 5.67 Bn | 21.24 | 0.78 | 5.41 Bn |
| 132 | ASB | Associated Banc-Corp | secondary | F-01 | Banking | FG-01 | 5.66 Bn | 11.47 | 111.60 | 4.71 Bn |
| 133 | AUB | Atlantic Union Bankshares Corp | secondary | F-01 | Banking | FG-01 | 5.60 Bn | 11.78 | 3.63 | 4.51 Bn |
| 134 | ENVA | Enova International, Inc. | secondary | F-04 | Lending and Credit | FG-02 | 5.54 Bn | 15.59 | 1.61 | 5.42 Bn |
| 135 | RITM | Rithm Capital Corp. | secondary | F-08 | Lending and Credit | FG-02 | 5.42 Bn | 16.18 | 1.07 | 5.42 Bn |
| 136 | AMRX | Amneal Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.41 Bn | 25.11 | 1.73 | 5.28 Bn |
| 137 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.10 Bn | -17.76 | — | 5.10 Bn |
| 138 | HASI | HA Sustainable Infrastructure Capital, Inc. | secondary | F-11 | Asset and Wealth Management | FG-03 | 4.83 Bn | 54.27 | 10.43 | 4.58 Bn |
| 139 | FMCQF | Fresenius Medical Care AG | secondary | H-14 | Healthcare Providers | HG-04 | 4.79 Bn | 4.57 | 0.17 | 4.09 Bn |
| 140 | ACAD | Acadia Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.73 Bn | 12.43 | 4.15 | 3.77 Bn |
| 141 | EWTX | Edgewise Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.62 Bn | -23.44 | — | 4.62 Bn |
| 142 | SKY | Champion Homes, Inc. | secondary | D-09 | Homebuilding | DG-03 | 4.53 Bn | — | — | 3.89 Bn |
| 143 | MARA | MARA Holdings, Inc. | secondary | T-59 | Fintech | TG-09 | 4.45 Bn | -1.29 | 5.53 | 4.01 Bn |
| 144 | UCB | United Community Banks Inc | secondary | F-01 | Banking | FG-01 | 4.19 Bn | 11.32 | 3.78 | 3.65 Bn |
| 145 | DFTX | Definium Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.17 Bn | -11.78 | — | 4.17 Bn |
| 146 | INDV | Indivior Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.08 Bn | 11.50 | 3.07 | 3.86 Bn |
| 147 | OPLN | OPENLANE, Inc. | secondary | T-51 | Internet Platforms | TG-08 | 4.02 Bn | -47.23 | 1.94 | 3.83 Bn |
| 148 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.00 Bn | -7.82 | 1,109.64 | 4.00 Bn |
| 149 | MANE | Veradermics, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.96 Bn | -45.98 | — | 3.96 Bn |
| 150 | ABG | Asbury Automotive Group Inc | secondary | D-37 | Retail | DG-10 | 3.85 Bn | 7.56 | 0.21 | 3.81 Bn |
| 151 | CPRX | CATALYST PHARMACEUTICALS, INC. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 6.45 | 3.09 Bn |
| 152 | SKYW | Skywest Inc | secondary | I-18 | Transportation | IG-05 | 3.76 Bn | 9.17 | 0.90 | 3.16 Bn |
| 153 | ELVN | Enliven Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.72 Bn | -44.16 | — | 3.72 Bn |
| 154 | RNST | Renasant Corp | secondary | F-01 | Banking | FG-01 | 3.69 Bn | 11.75 | 3.37 | 2.81 Bn |
| 155 | OGN | Organon & Co. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.58 Bn | 17.15 | 0.59 | 2.45 Bn |
| 156 | TARS | Tarsus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.56 Bn | -75.82 | 5.87 | 3.11 Bn |
| 157 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.42 Bn | -7.44 | 29.24 | 2.72 Bn |
| 158 | FFBC | First Financial Bancorp /Oh/ | secondary | F-01 | Banking | FG-01 | 3.35 Bn | 11.73 | 3.32 | 3.35 Bn |
| 159 | SII | Sprott Inc. | secondary | F-09 | Asset and Wealth Management | FG-03 | 3.26 Bn | 31.05 | 8.15 | 3.07 Bn |
| 160 | BKU | BankUnited, Inc. | secondary | F-01 | Banking | FG-01 | 3.25 Bn | 11.89 | 137.24 | 2.89 Bn |
| 161 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.90 Bn | -10.72 | 593.06 | 2.38 Bn |
| 162 | BANC | Banc Of California, Inc. | secondary | F-01 | Banking | FG-01 | 2.84 Bn | -45.75 | 3.22 | 0.03 Bn |
| 163 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.84 Bn | -8.32 | 77.26 | 2.40 Bn |
| 164 | HOG | Harley-Davidson, Inc. | secondary | D-04 | Automobiles and Components | DG-01 | 2.82 Bn | 14.40 | 0.66 | 0.92 Bn |
| 165 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.75 Bn | -14.60 | 6.11 | 2.04 Bn |
| 166 | NAMS | NewAmsterdam Pharma Co N.V. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.74 Bn | -10.57 | 385.30 | 2.74 Bn |
| 167 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.66 Bn | -22.44 | 2.03 | 2.57 Bn |
| 168 | FBNC | First Bancorp /Nc/ | secondary | F-01 | Banking | FG-01 | 2.63 Bn | 19.75 | 5.29 | 2.08 Bn |
| 169 | TAK | Takeda Pharmaceutical Co Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.60 Bn | 4.52 | 0.06 | -3.20 Bn |
| 170 | BBT | Beacon Financial Corp | secondary | F-01 | Banking | FG-01 | 2.60 Bn | 16.25 | 81.89 | 1.38 Bn |
| 171 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.58 Bn | -79.44 | — | 2.58 Bn |
| 172 | MLYS | Mineralys Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.55 Bn | -7.30 | — | 2.55 Bn |
| 173 | TRVI | Trevi Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.49 Bn | -59.00 | — | 2.49 Bn |
| 174 | BEIGF | BeOne Medicines Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.48 Bn | 3.74 | 0.40 | -2.62 Bn |
| 175 | AGM | Federal Agricultural Mortgage Corp | secondary | F-05 | Lending and Credit | FG-02 | 2.43 Bn | 12.14 | 5.45 | 1.39 Bn |
| 176 | SUPN | Supernus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.42 Bn | -28.38 | 3.07 | 2.04 Bn |
| 177 | MBIN | Merchants Bancorp | secondary | F-01 | Banking | FG-01 | 2.41 Bn | 10.55 | 3.38 | 1.57 Bn |
| 178 | HRMY | Harmony Biosciences Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.38 Bn | 13.32 | 2.48 | 1.57 Bn |
| 179 | PBI | Pitney Bowes Inc /De/ | secondary | I-30 | Business Services | IG-06 | 2.32 Bn | 15.28 | 1.67 | 2.04 Bn |
| 180 | EFSC | Enterprise Financial Services Corp | secondary | F-01 | Banking | FG-01 | 2.31 Bn | 12.37 | 2.97 | 1.76 Bn |
| 181 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.29 Bn | -2.10 | 0.21 | 0.46 Bn |
| 182 | PLUS | Eplus Inc | secondary | T-64 | Technology Services | TG-11 | 2.29 Bn | 16.03 | 0.91 | 1.84 Bn |
| 183 | TRN | Trinity Industries Inc | secondary | I-11 | Machinery | IG-02 | 2.25 Bn | 6.36 | 1.10 | 2.09 Bn |
| 184 | LTC | Ltc Properties Inc | secondary | R-07 | Property REITs | RG-01 | 2.20 Bn | 16.34 | 6.33 | 2.20 Bn |
| 185 | NUVB | Nuvation Bio Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.19 Bn | -20.21 | 12.86 | 2.19 Bn |
| 186 | PVLA | Palvella Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.14 Bn | -40.45 | — | 1.83 Bn |
| 187 | TBBK | Bancorp, Inc. | secondary | F-02 | Banking | FG-01 | 2.11 Bn | 9.45 | 14.03 | 2.03 Bn |
| 188 | AUPH | Aurinia Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.09 Bn | 6.64 | 6.69 | 1.64 Bn |
| 189 | SRCE | 1St Source Corp | secondary | F-01 | Banking | FG-01 | 2.07 Bn | 12.11 | 69.80 | 2.07 Bn |
| 190 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.06 Bn | -5.36 | 3.86 | 1.71 Bn |
| 191 | BLX | Bladex, Inc. | secondary | F-01 | Banking | FG-01 | 2.05 Bn | 1.50 | 5.81 | 2.04 Bn |
| 192 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.95 Bn | -4.70 | 1,952.70 | 1.95 Bn |
| 193 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.92 Bn | -3.27 | — | 1.65 Bn |
| 194 | CMRE | Costamare Inc. | secondary | I-21 | Transportation | IG-05 | 1.80 Bn | 5.65 | 2.10 | 1.43 Bn |
| 195 | SMA | SmartStop Self Storage REIT, Inc. | secondary | R-08 | Property REITs | RG-01 | 1.77 Bn | 61.37 | 5.77 | 1.73 Bn |
| 196 | BY | Byline Bancorp, Inc. | secondary | F-01 | Banking | FG-01 | 1.70 Bn | 11.36 | 3.67 | 1.48 Bn |
| 197 | QCRH | Qcr Holdings Inc | secondary | F-01 | Banking | FG-01 | 1.67 Bn | 19.96 | 10.49 | 0.84 Bn |
| 198 | EFC | Ellington Financial Inc. | secondary | F-08 | Lending and Credit | FG-02 | 1.67 Bn | 11.75 | 3.66 | 1.42 Bn |
| 199 | CASH | Pathward Financial, Inc. | secondary | F-02 | Banking | FG-01 | 1.66 Bn | 9.40 | 11.07 | 1.51 Bn |
| 200 | TRIN | Trinity Capital Inc. | secondary | F-07 | Lending and Credit | FG-02 | 1.61 Bn | 9.48 | 4.80 | 1.59 Bn |
| 201 | BPOPO | Popular, Inc. | secondary | F-01 | Banking | FG-01 | 1.61 Bn | 1.67 | 3.99 | 1.61 Bn |
| 202 | IIPR | Innovative Industrial Properties Inc | secondary | R-04 | Property REITs | RG-01 | 1.61 Bn | 12.37 | 6.09 | 1.61 Bn |
| 203 | ETON | Eton Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.60 Bn | 167.75 | 15.98 | 1.58 Bn |
| 204 | TFIN | Triumph Financial, Inc. | secondary | F-01 | Banking | FG-01 | 1.60 Bn | 45.08 | 28.01 | 0.70 Bn |
| 205 | BC-PC | Brunswick Corp | secondary | D-04 | Automobiles and Components | DG-01 | 1.58 Bn | -40.47 | 0.28 | 1.27 Bn |
| 206 | INVA | Innoviva, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.52 Bn | 7.76 | 2.96 | 0.95 Bn |
| 207 | ANIP | Ani Pharmaceuticals Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | 13.84 | 1.53 | 1.13 Bn |
| 208 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | -9.11 | 20.12 | 1.21 Bn |
| 209 | CSWC | Capital Southwest Corp | secondary | F-07 | Lending and Credit | FG-02 | 1.47 Bn | 21.20 | 6.20 | 1.41 Bn |
| 210 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.46 Bn | -3.17 | 2.04 | 1.17 Bn |
| 211 | TRTN-PA | Triton International Ltd | secondary | I-11 | Machinery | IG-02 | 1.42 Bn | -2.78 | 19.72 | 1.42 Bn |
| 212 | TMP | Tompkins Financial Corp | secondary | F-01 | Banking | FG-01 | 1.40 Bn | 8.01 | 3.09 | 1.40 Bn |
| 213 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.40 Bn | -8.55 | — | 1.40 Bn |
| 214 | LBRX | Lb Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.40 Bn | -23.08 | — | 1.40 Bn |
| 215 | PEBO | Peoples Bancorp Inc | secondary | F-01 | Banking | FG-01 | 1.39 Bn | -40.73 | 54.70 | 1.21 Bn |
| 216 | HROW | Harrow, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.37 Bn | -40.88 | 4.96 | 1.28 Bn |
| 217 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.34 Bn | 78.39 | 34.82 | 1.34 Bn |
| 218 | XERS | Xeris Biopharma Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.33 Bn | -77.68 | 3.98 | 1.21 Bn |
| 219 | CNF | CNFinance Holdings Ltd. | secondary | F-05 | Lending and Credit | FG-02 | 1.33 Bn | -27.01 | 26.29 | 1.33 Bn |
| 220 | GBX | Greenbrier Companies Inc | secondary | I-11 | Machinery | IG-02 | 1.32 Bn | 14.63 | 0.50 | 1.05 Bn |
| 221 | GOLD | Gold.com, Inc. | secondary | D-36 | Retail | DG-10 | 1.25 Bn | 15.18 | 0.05 | 0.67 Bn |
| 222 | MSDL | Morgan Stanley Direct Lending Fund | secondary | F-07 | Lending and Credit | FG-02 | 1.24 Bn | 35.66 | 3.32 | 1.16 Bn |
| 223 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.20 Bn | -25.11 | — | 0.98 Bn |
| 224 | WLFC | Willis Lease Finance Corp | secondary | I-01 | Aerospace and Defense | IG-01 | 1.19 Bn | 13.80 | 1.55 | 1.19 Bn |
| 225 | OLMA | Olema Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.13 Bn | -5.55 | — | 1.13 Bn |
| 226 | OPK | Opko Health, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.12 Bn | -29.60 | 1.91 | 0.82 Bn |
| 227 | OCSL | Oaktree Specialty Lending Corp | secondary | F-07 | Lending and Credit | FG-02 | 1.10 Bn | 20.35 | 2.43 | 1.06 Bn |
| 228 | HTT | High Templar Tech Ltd | secondary | F-04 | Lending and Credit | FG-02 | 1.07 Bn | 10.85 | 187.65 | 0.16 Bn |
| 229 | KURA | Kura Oncology, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.04 Bn | -4.38 | 13.49 | 1.04 Bn |
| 230 | NBBK | NB Bancorp, Inc. | secondary | F-01 | Banking | FG-01 | 1.00 Bn | 16.93 | 3.87 | 0.60 Bn |
| 231 | PCRX | Pacira BioSciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.00 Bn | 68.27 | 1.34 | 0.75 Bn |
| 232 | ESQ | Esquire Financial Holdings, Inc. | secondary | F-01 | Banking | FG-01 | 0.97 Bn | 18.42 | 6.09 | 0.73 Bn |
| 233 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.94 Bn | -68.13 | — | 0.89 Bn |
| 234 | SGP | SpyGlass Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.92 Bn | -48.72 | — | 0.92 Bn |
| 235 | DSGN | Design Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.92 Bn | -11.33 | — | 0.71 Bn |
| 236 | ABX | Abacus Global Management, Inc. | secondary | F-11 | Asset and Wealth Management | FG-03 | 0.90 Bn | 32.05 | 3.38 | 0.88 Bn |
| 237 | LXRX | Lexicon Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.89 Bn | -14.16 | 21.48 | 0.70 Bn |
| 238 | SMBK | Smartfinancial Inc. | secondary | F-01 | Banking | FG-01 | 0.85 Bn | 15.33 | 3.98 | 0.37 Bn |
| 239 | EGBN | Eagle Bancorp Inc | secondary | F-01 | Banking | FG-01 | 0.84 Bn | -17.34 | 2.79 | 0.84 Bn |
| 240 | PGC | Peapack Gladstone Financial Corp | secondary | F-01 | Banking | FG-01 | 0.80 Bn | 15.53 | 2.53 | 0.80 Bn |
| 241 | CGBD | Carlyle Secured Lending, Inc. | secondary | F-07 | Lending and Credit | FG-02 | 0.79 Bn | 21.36 | 3.05 | 0.74 Bn |
| 242 | HTB | HomeTrust Bancshares, Inc. | secondary | F-01 | Banking | FG-01 | 0.78 Bn | 12.02 | 3.61 | 0.50 Bn |
| 243 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.78 Bn | -9.78 | 94.74 | 0.78 Bn |
| 244 | VSTM | Verastem, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.76 Bn | -6.60 | 8.70 | 0.63 Bn |
| 245 | COLL | Collegium Pharmaceutical, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.74 Bn | 15.54 | 0.92 | 0.60 Bn |
| 246 | CUBB | Customers Bancorp, Inc. | secondary | F-01 | Banking | FG-01 | 0.74 Bn | 2.61 | 0.80 | -3.44 Bn |
| 247 | CTO | CTO Realty Growth, Inc. | secondary | R-03 | Property REITs | RG-01 | 0.73 Bn | 16.18 | 4.52 | 0.73 Bn |
| 248 | ZVRA | Zevra Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.71 Bn | 12.25 | 5.24 | 0.49 Bn |
| 249 | PFIS | Peoples Financial Services Corp. | secondary | F-01 | Banking | FG-01 | 0.71 Bn | 12.44 | 53.83 | 0.21 Bn |
| 250 | VEL | Velocity Financial, Inc. | secondary | F-05 | Lending and Credit | FG-02 | 0.70 Bn | 6.54 | -2.03 | -6.75 Bn |
| 251 | PHAT | Phathom Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.70 Bn | -7.14 | 2.92 | 0.52 Bn |
| 252 | IVEVF | Inventiva S.A. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.69 Bn | 7.19 | 132.94 | 0.69 Bn |
| 253 | GYRE | Gyre Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.69 Bn | -37.19 | 5.75 | 0.63 Bn |
| 254 | SLRC | SLR Investment Corp. | secondary | F-07 | Lending and Credit | FG-02 | 0.68 Bn | 7.58 | 3.22 | 0.68 Bn |
| 255 | AQST | Aquestive Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.65 Bn | -8.37 | 12.11 | 0.56 Bn |
| 256 | LEGH | Legacy Housing Corp | secondary | D-09 | Homebuilding | DG-03 | 0.64 Bn | 12.42 | 3.55 | 0.61 Bn |
| 257 | CRMD | CorMedix Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | 4.98 | 1.67 | 0.37 Bn |
| 258 | MPLT | MapLight Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.61 Bn | -3.04 | — | 0.61 Bn |
| 259 | MBNKO | Medallion Financial Corp | secondary | F-01 | Banking | FG-01 | 0.60 Bn | — | — | 0.56 Bn |
| 260 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.59 Bn | -337,821.64 | — | 0.59 Bn |
| 261 | NPB | Northpointe Bancshares Inc | secondary | F-01 | Banking | FG-01 | 0.59 Bn | 7.56 | 2.33 | 0.05 Bn |
| 262 | CBNK | Capital Bancorp Inc | secondary | F-01 | Banking | FG-01 | 0.59 Bn | 10.42 | 23.87 | 0.17 Bn |
| 263 | FBIZ | First Business Financial Services, Inc. | secondary | F-01 | Banking | FG-01 | 0.59 Bn | 10.71 | 3.29 | 0.42 Bn |
| 264 | NRIM | Northrim Bancorp Inc | secondary | F-01 | Banking | FG-01 | 0.57 Bn | 8.36 | 117.67 | 0.53 Bn |
| 265 | MSIF | Msc Income Fund, Inc. | secondary | F-07 | Lending and Credit | FG-02 | 0.57 Bn | 21.57 | 4.04 | 0.54 Bn |
| 266 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.57 Bn | 1,145.05 | 5.93 | 0.47 Bn |
| 267 | CIVB | Civista Bancshares, Inc. | secondary | F-01 | Banking | FG-01 | 0.56 Bn | 10.87 | 28.67 | 0.55 Bn |
| 268 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.55 Bn | -5.64 | 55.61 | 0.46 Bn |
| 269 | EOLS | Evolus, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.53 Bn | -15.57 | 1.69 | 0.49 Bn |
| 270 | NVCT | Nuvectis Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.53 Bn | -17.63 | — | 0.53 Bn |
| 271 | OVID | Ovid Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -15.17 | 330.54 | 0.41 Bn |
| 272 | CSV | Carriage Services Inc | secondary | D-30 | Consumer Services | DG-09 | 0.50 Bn | 10.56 | 1.21 | 0.50 Bn |
| 273 | SPRY | ARS Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.50 Bn | -2.27 | 4.30 | 0.36 Bn |
| 274 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.50 Bn | -7.40 | 22.25 | 0.22 Bn |
| 275 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.49 Bn | -10.27 | 78.36 | 0.26 Bn |
| 276 | AHRT | AH Realty Trust, Inc. | secondary | R-03 | Property REITs | RG-01 | 0.48 Bn | -10.00 | 2.24 | 0.48 Bn |
| 277 | XFOR | X4 Pharmaceuticals, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.43 Bn | -4.82 | 27.43 | 0.24 Bn |
| 278 | PALI | Palisade Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.43 Bn | -12.31 | 868.78 | 0.31 Bn |
| 279 | TTRX | Turn Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -53.73 | — | 0.41 Bn |
| 280 | IKT | Inhibikase Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -6.26 | — | 0.25 Bn |
| 281 | SAJ | Saratoga Investment Corp. | secondary | F-07 | Lending and Credit | FG-02 | 0.41 Bn | -23.30 | 4.24 | 0.03 Bn |
| 282 | VTVT | vTv Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.40 Bn | -84.15 | 10.86 | 0.40 Bn |
| 283 | EVMN | Evommune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.40 Bn | -4.18 | 39.55 | 0.19 Bn |
| 284 | FRST | Primis Financial Corp. | secondary | F-01 | Banking | FG-01 | 0.39 Bn | 7.50 | 1.77 | 0.22 Bn |
| 285 | OPRT | Oportun Financial Corp | secondary | F-04 | Lending and Credit | FG-02 | 0.38 Bn | 19.41 | 0.40 | 0.24 Bn |
| 286 | SNDL | SNDL Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 0.36 Bn | -17.40 | 0.53 | 0.22 Bn |
| 287 | DIN | Dine Brands Global, Inc. | secondary | D-17 | Restaurants | DG-06 | 0.34 Bn | 54.41 | 0.38 | 0.19 Bn |
| 288 | AVBH | Avidbank Holdings, Inc. | secondary | F-01 | Banking | FG-01 | 0.33 Bn | -23.67 | 20.06 | 0.17 Bn |
| 289 | COSO | CoastalSouth Bancshares, Inc. | secondary | F-01 | Banking | FG-01 | 0.33 Bn | 12.14 | 163.04 | 0.30 Bn |
| 290 | SION | Sionna Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | -3.39 | — | 0.33 Bn |
| 291 | FSBW | FS Bancorp, Inc. | secondary | F-01 | Banking | FG-01 | 0.33 Bn | 9.65 | 2.09 | 0.30 Bn |
| 292 | ACHV | Achieve Life Sciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | — | — | 0.32 Bn |
| 293 | HRZN | Horizon Technology Finance Corp | secondary | F-07 | Lending and Credit | FG-02 | 0.31 Bn | 4.47 | 3.25 | 0.31 Bn |
| 294 | VNDA | Vanda Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -1.11 | 1.41 | 0.13 Bn |
| 295 | IMRX | Immuneering Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -5.13 | — | 0.30 Bn |
| 296 | EBS | Emergent BioSolutions Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -1.67 | 0.38 | 0.15 Bn |
| 297 | FULC | Fulcrum Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -3.27 | — | 0.29 Bn |
| 298 | FNRN | First Northern Community Bancorp | secondary | F-01 | Banking | FG-01 | 0.28 Bn | 12.41 | 102.74 | -0.09 Bn |
| 299 | RWAY | Runway Growth Finance Corp. | secondary | F-07 | Lending and Credit | FG-02 | 0.27 Bn | -2.93 | 2.06 | 0.26 Bn |
| 300 | RC | Ready Capital Corp | secondary | F-08 | Lending and Credit | FG-02 | 0.27 Bn | -0.48 | -48.02 | 0.27 Bn |